Patents by Inventor Steven A. Bender
Steven A. Bender has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240093793Abstract: A fluid transfer system includes a valve tree, the valve tree having a master valve having a flow axis and a header. The fluid transfer system further includes a coupler disposed between, connected to, and in fluid communication with, the valve tree and the header. The coupler has a fixed length and includes a coupler multi-path flow connector in fluid communication with the valve tree. The coupler also includes a flow control valve having a flow axis, the flow control valve directly coupled to the coupler multi-path flow connector and in fluid communication with the header.Type: ApplicationFiled: November 29, 2023Publication date: March 21, 2024Inventors: Chad BABINEAUX, Scott BENDER, Steven BENDER, Jerod BUSHMAN, Jason CADE, Brenton J. GRESKA
-
Publication number: 20240092918Abstract: This application discloses anti-CCR7 antibodies, antigen binding fragments thereof, and antibody drug conjugates of said antibodies or antigen binding fragments. The invention also relates to methods of treating or preventing cancer using the antibodies, antigen binding fragments, and antibody drug conjugates. Also disclosed herein are methods of making the antibodies, antigen binding fragments, and antibody drug conjugates, and methods of using the antibodies and antigen binding fragments as diagnostic reagents.Type: ApplicationFiled: February 3, 2023Publication date: March 21, 2024Inventors: Steven BENDER, Tracy CHARLTON, Anna GALKIN, Bernhard Hubert GEIERSTANGER, Scott Martin GLASER, Shailaja KASIBHATLA, Mark KNUTH, Sabine ROTTMANN, Sarah RUE, Glen SPRAGGON, Tetsuo UNO
-
Patent number: 11634497Abstract: This application discloses anti-CCR7 antibodies, antigen binding fragments thereof, and antibody drug conjugates of said antibodies or antigen binding fragments. The invention also relates to methods of treating or preventing cancer using the antibodies, antigen binding fragments, and antibody drug conjugates. Also disclosed herein are methods of making the antibodies, antigen binding fragments, and antibody drug conjugates, and methods of using the antibodies and antigen binding fragments as diagnostic reagents.Type: GrantFiled: February 1, 2018Date of Patent: April 25, 2023Assignee: NOVARTIS AGInventors: Steven Bender, Tracy Charlton, Anna Galkin, Bernhard Hubert Geierstanger, Scott Martin Glaser, Shailaja Kasibhatla, Mark Knuth, Sabine Rottmann, Sarah Rue, Glen Spraggon, Tetsuo Uno
-
Publication number: 20230053449Abstract: Provided herein are antibodies to DC-SIGN, conjugates of DC-SiGN antibodies, and DC-SiGN antibody fusion proteins and the use of such antibodies, conjugates, and fusion proteins for the treatment of diseases such as cancer.Type: ApplicationFiled: October 30, 2019Publication date: February 23, 2023Inventors: Lisa BARNETT, Steven BENDER, Alex Cortez, Sarah COX, Jonathan DEANE, Scott Martin GLASER, Ben WEN, Tom Yao-Hsiang WU
-
Patent number: 11536370Abstract: The present disclosure provides an improved bellows type seal. In the present disclosure, the bellows of the seal dampen resulting in the seal having a longer useful life and can withstand higher loads. The seal includes a damper assembly that includes a spring and a band that are engaged on the exterior of a bellows for dampening vibrations.Type: GrantFiled: November 20, 2020Date of Patent: December 27, 2022Assignee: Eaton Intelligent Power LimitedInventors: Steven Bender, Jeffrey Lavin
-
Publication number: 20210170043Abstract: Provided herein are immunoconjugates comprising an anti-DC-SIGN antibody conjugated to a STING agonist. Also disclosed are methods of making the immunoconjugates and methods of treating cancer using the immunoconjugates.Type: ApplicationFiled: October 30, 2019Publication date: June 10, 2021Inventors: Lisa BARNETT, Steven BENDER, Charles Y. CHO, Sarah COX, Jonathan Deane, Scott Martin GLASER, Xueshi Hao, Shailaja KASIBHATLA, Weijia OU, Tetsuo UNO, Yongqin WAN, Ben WEN, Tom Yao-Hsiang WU
-
Publication number: 20210156472Abstract: The present disclosure provides an improved bellows type seal. In the present disclosure, the bellows of the seal dampen resulting in the seal having a longer useful life and can withstand higher loads. The seal includes a damper assembly that includes a spring and a band that are engaged on the exterior of a bellows for dampening vibrations.Type: ApplicationFiled: November 20, 2020Publication date: May 27, 2021Inventors: Steven Bender, Jeffrey Lavin
-
Publication number: 20200216548Abstract: This application discloses anti-CCR7 antibodies, antigen binding fragments thereof, and antibody drug conjugates of said antibodies or antigen binding fragments. The invention also relates to methods of treating or preventing cancer using the antibodies, antigen binding fragments, and antibody drug conjugates. Also disclosed herein are methods of making the antibodies, antigen binding fragments, and antibody drug conjugates, and methods of using the antibodies and antigen binding fragments as diagnostic reagents.Type: ApplicationFiled: February 1, 2018Publication date: July 9, 2020Inventors: Steven BENDER, Tracy CHARLTON, Anna GALKIN, Bernhard Hubert GEIERSTANGER, Scott Martin GLASER, Shailaja KASIBHATLA, Mark KNUTH, Sabine ROTTMANN, Sarah RUE, Glen SPRAGGON, Tetsuo UNO
-
Publication number: 20200208747Abstract: A fluid transfer system includes a valve tree, the valve tree having a master valve having a flow axis and a header. The fluid transfer system further includes a coupler disposed between, connected to, and in fluid communication with, the valve tree and the header. The coupler has a fixed length and includes a coupler multi-path flow connector in fluid communication with the valve tree. The coupler also includes a flow control valve having a flow axis, the flow control valve directly coupled to the coupler multi-path flow connector and in fluid communication with the header.Type: ApplicationFiled: September 11, 2019Publication date: July 2, 2020Inventors: Chad BABINEAUX, Scott BENDER, Steven BENDER, Jerod BUSHMAN, Jason CADE, Brenton J. GRESKA, Glenn C. PARKS, JR.
-
Publication number: 20080034218Abstract: A user recognition and identification system and method to identify keyboard users. Key text is evaluated against previously recorded keystrokes by the user for the presence of repeatable patterns that are unique to an individual. Users may be prompted with a rhythm to emulate by a rhythm guidance presenter. The presentation of the rhythm enables faster learning and emulation by keyboard users.Type: ApplicationFiled: June 4, 2007Publication date: February 7, 2008Inventor: Steven Bender
-
Publication number: 20080028232Abstract: A user recognition and identification system and method to identify keyboard users. Key text is evaluated against previously recorded keystrokes by the user for the presence of repeatable patterns that are unique to an individual. Rhythms associated with passwords are screened compared to a database of banned rhythms.Type: ApplicationFiled: June 4, 2007Publication date: January 31, 2008Inventor: Steven Bender
-
Publication number: 20080028231Abstract: A user recognition and identification system and method to identify keyboard users. Key text is evaluated against previously recorded keystrokes by the user for the presence of repeatable patterns that are unique to an individual. User profiles are updated as their repeatable patterns slowly change over time.Type: ApplicationFiled: June 4, 2007Publication date: January 31, 2008Inventor: Steven Bender
-
Publication number: 20070162763Abstract: A user recognition and identification system and method is presented in which text entered by a user at a keyboard is evaluated against previously recorded keystrokes by the user for the presence of repeatable patterns that are unique to an individual.Type: ApplicationFiled: March 6, 2007Publication date: July 12, 2007Inventors: Steven Bender, Howard Postley
-
Patent number: 7141581Abstract: Indazole compounds that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction and thereby modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.Type: GrantFiled: August 12, 2003Date of Patent: November 28, 2006Assignee: Agouron Pharmaceuticals, Inc.Inventors: Steven Bender, Dana Hu-Lowe, David Ray Shalinsky
-
Publication number: 20050197492Abstract: Polypeptides containing the kinase domain of a VEGFR are described. Also described are crystal structures of these polypeptides, including the crystal structures of VEGFR2KD:ligand complexes. The atomic coordinates derived from the crystal structures provide a three-dimensional description of the ligand-binding pocket of the kinase domain useful in drug discovery and design for the identification and design of modulators of kinase activity.Type: ApplicationFiled: April 15, 2004Publication date: September 8, 2005Inventors: Steven Bender, Robert Kania, Michele McTigue, Cynthia Palmer, Chris Pinko, John Wickersham
-
Publication number: 20050124662Abstract: Indazole compounds that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction and thereby modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.Type: ApplicationFiled: November 18, 2004Publication date: June 9, 2005Inventors: Robert Kania, Steven Bender, Allen Borchardt, Stephan Cripps, Cynthia Louise Palmer, Anna Maria Tempczyk-Russell, Michael Varney, Michael Raymond Collins
-
Publication number: 20050038097Abstract: Indazole compounds that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction and thereby modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.Type: ApplicationFiled: August 12, 2003Publication date: February 17, 2005Inventors: Steven Bender, Donald Skalitzky, Dana Hu-Lowe
-
Patent number: 5450316Abstract: A cryogenic vacuum pump includes, in an integral assembly, temperature sensors and heaters associated with the first and second stages of the cryopumping array, a roughing valve and a purge valve. An electronic module removably coupled in the assembly responds to all sensors and controls all operations of the cryopump including regeneration thereof. System parameters are stored in a nonvolatile memory in the module. Included in the regeneration procedures are an auto-zero of the pressure gauge, heating of the array throughout rough pumping, and a change in pressure rate test to determine stall in rough pumping. The electronic module also restarts the system after power failure, limits use of a pressure gauge to safe conditions, provides warnings before allowing opening of the valves while the cryopump is operating and stores sensor calibration information. Control through a control pad on the pump may be limited by a password requirement. Password override is also provided.Type: GrantFiled: June 2, 1994Date of Patent: September 12, 1995Assignee: Helix Technology CorporationInventors: Peter W. Gaudet, Donald A. Olsen, Steven A. Bender
-
Patent number: 5157928Abstract: A cryogenic vacuum pump includes, in an integral assembly, temperature sensors and heaters associated with the first and second stages of the cryopumping array, a roughing valve and a purge valve. An electronic module removably coupled in the assembly responds to all sensors and controls all operations of the cryopump including regeneration thereof. System parameters are stored in a nonvolatile memory in the module. Included in the regeneration procedures are an auto-zero of the pressure gauge, heating of the array throughout rough pumping, and a change in pressure rate test to determine stall in rough pumping. The electronic module also restarts the system after power failure, limits use of a pressure gauge to safe conditions, provides warnings before allowing opening of the valves while the cryopump is operating and stores sensor calibration information. Control through a control pad on the pump may be limited by a password requirement. Password override is also provided.Type: GrantFiled: May 20, 1991Date of Patent: October 27, 1992Assignee: Helix Technology CorporationInventors: Peter W. Gaudet, Donald A. Olsen, Michael J. Eacobacci, John T. Harvell, Robert J. Lepofsky, David E. Roche, Steven A. Bender
-
Patent number: 4918930Abstract: A cryogenic vacuum pump includes, in an integral assembly, temperature sensors and heaters associated with the first and second stages of the cryopumping array, a roughing valve and a purge valve. An electronic module removably coupled in the assembly responds to all sensors and controls all operations of the cryopump including regeneration thereof. System parameters are stored in a nonvolatile memory in the module. Included in the regeneration procedures are an auto-zero of the pressure gauge, heating of the array throughout rough pumping, and a change in pressure rate test to determine stall in rough pumping. The electronic module also restarts the system after power failure, limits use of a pressure gauge to safe conditions, provides warnings before allowing opening of the valves while the cryopump is operating and stores sensor calibration information. Control through a control pad on the pump may be limited by a password requirement. Password override is also provided.Type: GrantFiled: September 13, 1988Date of Patent: April 24, 1990Assignee: Helix Technology CorporationInventors: Peter W. Gaudet, Donald A. Olsen, Michael J. Eacobacci, John T. Harvell, Robert J. Lepofsky, David E. Roche, Steven A. Bender